Predicting the Likelihood of an IDH1 or IDH2 Mutation in Patients Diagnosed with Infiltrative Gliomas

被引：0
|
作者：
Horbinski, Craig [1 ]
Voronovich, Zoya [2 ]
Clark, Kenneth [2 ]
Hands, Isaac [1 ]
Mannas, Jonathan [1 ]
Walsh, Meggen [1 ]
Nikiforova, Marina [2 ]
Durbin, Eric [1 ]
Weiss, Heidi [1 ]
Chen, Li [1 ]
机构：
[1] Univ Kentucky, Lexington, KY 40506 USA
[2] Univ Pittsburgh, Pittsburgh, PA 15260 USA
来源：
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY | 2014年 / 73卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1
引用
收藏
页码：585 / 585
页数：1
相关论文
共 50 条
  • [41] All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2
    Labussiere, M.
    Idbaih, A.
    Wang, X. -W.
    Marie, Y.
    Boisselier, B.
    Falet, C.
    Paris, S.
    Laffaire, J.
    Carpentier, C.
    Criniere, E.
    Ducray, F.
    El Hallani, S.
    Mokhtari, K.
    Hoang-Xuan, K.
    Delattre, J. -Y.
    Sanson, M.
    NEUROLOGY, 2010, 74 (23) : 1886 - 1890
  • [42] IDH1 reactivity and mosaic IDH1 or IDH2 somatic mutations in solitary enchondroma and enchondromatosis
    Saiji, E.
    Biderbost, C. Cerato
    Berczy, M.
    Rougemont, A. -L.
    VIRCHOWS ARCHIV, 2015, 467 : S167 - S167
  • [43] Mutational analysis for IDH1 and IDH2 in pediatric leukemia
    Hiwatari, Mitsuteru
    Takita, Junko
    Nishimura, Riki
    Okubo, Jun
    Oki, Kentaro
    Sanada, Masashi
    Sotomatsu, Manabu
    Kikuchi, Akira
    Igarashi, Takashi
    Hayashi, Yasuhide
    Ogawa, Seishi
    CANCER RESEARCH, 2012, 72
  • [44] IDH1 and IDH2 mutations in pediatric acute leukemia
    A K Andersson
    D W Miller
    J A Lynch
    A S Lemoff
    Z Cai
    S B Pounds
    I Radtke
    B Yan
    J D Schuetz
    J E Rubnitz
    R C Ribeiro
    S C Raimondi
    J Zhang
    C G Mullighan
    S A Shurtleff
    B A Schulman
    J R Downing
    Leukemia, 2011, 25 : 1570 - 1577
  • [45] IDH1 and IDH2 mutations in pediatric acute leukemia
    Andersson, A. K.
    Miller, D. W.
    Lynch, J. A.
    Lemoff, A. S.
    Cai, Z.
    Pounds, S. B.
    Radtke, I.
    Yan, B.
    Schuetz, J. D.
    Rubnitz, J. E.
    Ribeiro, R. C.
    Raimondi, S. C.
    Zhang, J.
    Mullighan, C. G.
    Shurtleff, S. A.
    Schulman, B. A.
    Downing, J. R.
    LEUKEMIA, 2011, 25 (10) : 1570 - 1577
  • [46] A COMBINED APPROACH WITH R132H MUTATION SPECIFIC IDH1 ANTIBODY FOLLOWED BY IDH1/IDH2 SEQUENCING IS IDEAL FOR THE DETECTION OF IDH1/2 MUTATIONS
    Kurian, Kathreena M.
    Crosby, Charlene
    Hopkins, Kirsten
    Williams, Maggie
    NEURO-ONCOLOGY, 2012, 14 : 1 - 1
  • [47] IDH1 and IDH2 Mutations Detected by Pyrosequencing in Cholangiocarcinoma
    Voss, J. S.
    Kerr, S. E.
    Fritcher, E. G. Barr
    Highsmith, W. E.
    Zhang, J.
    Roberts, L. R.
    Gores, G. J.
    Halling, K. C.
    Kipp, B. R.
    LABORATORY INVESTIGATION, 2012, 92 : 184A - 184A
  • [48] Mutations of IDH1 and IDH2 are not frequent in Multiple Myeloma
    Langer, C.
    Ibanez, M.
    Liebisch, P.
    Zenz, T.
    Knop, S.
    Einsele, H.
    Paschka, P.
    Doehner, H.
    Doehner, K.
    ONKOLOGIE, 2011, 34 : 159 - 159
  • [49] IDH1 and IDH2 Mutations Detected by Pyrosequencing in Cholangiocarcinoma
    Voss, J. S.
    Kerr, S. E.
    Fritcher, E. G. Barr
    Highsmith, W. E.
    Zhang, J.
    Roberts, L. R.
    Gores, G. J.
    Halling, K. C.
    Kipp, B. R.
    MODERN PATHOLOGY, 2012, 25 : 184A - 184A
  • [50] IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
    Cerchione, Claudio
    Romano, Alessandra
    Daver, Naval
    DiNardo, Courtney
    Jabbour, Elias Joseph
    Konopleva, Marina
    Ravandi-Kashani, Farhad
    Kadia, Tapan
    Martelli, Maria Paola
    Isidori, Alessandro
    Martinelli, Giovanni
    Kantarjian, Hagop
    FRONTIERS IN ONCOLOGY, 2021, 11
12345